Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic LeukemiaCooper Quartermaine, Daniel Addison, Adnan Shaaban et al.|JACC CardioOncology|2023Cited by 107
Ventricular arrhythmias and sudden death events following acalabrutinib initiationSeema A. Bhat, Daniel Addison, John Alan Gambril et al.|Blood|2022Cited by 68
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart AssociationRohan Khera, Tochukwu Okwuosa, Aarti Asnani et al.|Circulation Genomic and Precision Medicine|2025Cited by 61
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiationSunnia T. Chen, Daniel Addison, Leylah Azali et al.|Journal of Hematology & Oncology|2022Cited by 36
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated CardiotoxicityBenjamin Buck, Daniel Addison, Aaron Chum et al.|JAMA Oncology|2023Cited by 29